Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: Implications in metastasis and/or radiation response

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 3, 1997, Pages 197-203

  Patel, S ^a   Wang, F H ^a   Whiteside, T L ^b   Kasid, U ^a,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c Lombardi Cancer Centre   (United States)

Author keywords

Differential gene expression; Head and neck squamous cell carcinoma; Metastasis; Radiation therapy

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MALE; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIATION RESPONSE;

BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HLA-DP ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0031147984     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00065-6     Document Type: Article

References (22)

1. 1. Millon R. R., Cassisi N. J., Clark J. R., Cancers of the head and neck. In eds. V. T. De Vita, S. Hellman, S. A. Rosenberg. Principles and Practices of Oncology. J.B. Lippincott, Philadelphia, pp. 488-590, 1989.
2. 2. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M. and Ki, Hong W., Head and neck cancer. New England Journal of Medicine, 1993, 328 (3), 184-194.
3. 3. Jin, Y., Higashi, K., Mandahl, N., et al., Frequent rearrangement of chromosome bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes, Chromosomes and Cancer, 1990, 1, 198-204.
4. 4. Muller, D., Millon, R., Lidereau, R., et al., Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Oral Oncology, European Journal of Cancer, 1994, 30B, 113-120.
5. 5. Latif, F., Fivash, M., Glenn, G., et al., Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Research, 1992, 52, 1451-1456.
6. 6. Field, J. K., Oncogenes and tumour suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncology, European Journal of Cancer, 1992, 1, 67-76.
7. 7. Field, J. K., Spandidos, D. A., Stell, P. M., Vaughan, E. D., Evan, G. I. and Moore, J. P., Elevated expression of c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene, 1989, 4, 1463-1468.
8. 8. Riva, C., Lavieille, J-P., Reyt, E., Brambilla, E., Lunardi, J. and Brambilla, C., Differential c-myc, c-jun, c-raf, and p53 expression in squamous cell carcinoma of the head and neck: Implications in drug and radioresistance. Oral Oncology, European Journal of Cancer, 1995, 31B, 384-391.
9. 9. Kasid, U., Peifer, A., Brennan, T., et al, Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science, 1989, 243, 1354-1356.
10. 10. Patel, B. K. R. and Kasid, U., Nucleotide sequence analysis of the c-raf-1 cDNA and promoter from a radiation resistant human squamous cell carcinoma: Deletion within exon 17. Molecular Carcinogenesis, 1993, 8, 7-12.
11. 11. Patel B., Ray S., Whiteside T. L. W., Kasid U., Correlation of constitutive activation of raf-1 with morphological transformation and abrogation of tyrosine phosphorylation of distinct sets of proteins in human squamous carcinoma cells Molecular Carcinogenesis, 1997, 18, 1-6.
12. 12. Kasid U., Suy S., Dent P., Ray S., Whiteside T. L. W. and Sturgill T., Activation of Raf by ionizing radiation. Nature, 1996, 382, 813-816.
13. 13. Heo, D. S., Synderman, C., Gollin, S. M., et al., Biology, cytogenics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Research, 1989, 49, 5167-5175.
14. 14. Liang, P. and Pardee, A. B., Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science, 1992, 257, 967-971.
15. 15. Vogeli-Lange, R., Burchert, N., Boller, T., et al., Rapid selection and classification of positive clones generated by mRNA differential display. Nucleic Acids Research, 1996, 24 (7), 1385-1386.
16. 16. Maniatis T., Fritsch E. F., Aambrook J. Molecular Cloning: a Laboratory Manual. CSH Laboratory Press, Cold Spring Harbour, 1982.
17. 17. Sager, R., Anisowicz, A., Neveu, M., Liang, P. and Sotiropoulou, G., Identification by differential display of alpha-6 integrin as a candidate tumour suppressor gene. FASEB J, 1993, 7, 964-970.
18. 18. van Groningen, J. J. M., Bloemers, H. P. J. and Swart, G. W. M., Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Research, 1995, 55, 6237-6243.
19. 19. Sun, Y., Hegamyer, G. and Colborn, N. H., Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal Cells: One is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Research, 1994, 54, 1139-1144.
20. 20. Zhang, L. and Medina, D., Gene expression screening for specific genes associated with mouse mammary tumour development. Molecular Carcinogenesis, 1993, 8, 123-126.
21. 21. Koch, W. M., Dugan, E., Diaz, L. A. and Richtsmeier, W. J., Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma. Laryngoscope, 1988, 98, 511.
22. 22. Weichselbaum, R. R., Beckett, M., Schwanz, J. L. and Dritschilo, A., Radioresistant tumour cells are present in head and neck carcinomas that recur after radiotherapy. International Journal of Radiation, Oncology, Biology and Physics, 1988, 15, 575-579.